|
1
|
Spender LC and Inman GJ: Phosphoinositide
3-kinase/AKT/mTORC1/2 signaling determines sensitivity of Burkitt's
lymphoma cells to BH3 mimetics. Mol Cancer Res. 10:347–359. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schmitz R, Young RM, Ceribelli M, Jhavar
S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, et
al: Burkitt lymphoma pathogenesis and therapeutic targets from
structural and functional genomics. Nature. 490:116–120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fang X, Jiang Y, Feng L, Chen H, Zhen C,
Ding M and Wang X: Blockade of PI3K/AKT pathway enhances
sensitivity of Raji cells to chemotherapy through down-regulation
of HSP70. Cancer Cell Int. 13:482013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choudhury Y, Tay FC, Lam DH, Sandanaraj E,
Tang C, Ang BT and Wang S: Attenuated adenosine-to-inosine editing
of microRNA-376a* promotes invasiveness of glioblastoma
cells. J Clin Invest. 122:4059–4076. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piva R, Spandidos DA and Gambari R: From
microRNA functions to microRNA therapeutics: Novel targets and
novel drugs in breast cancer research and treatment (Review). Int J
Oncol. 43:985–994. 2013.PubMed/NCBI
|
|
9
|
Karpova MB, Schoumans J, Ernberg I, Henter
JI, Nordenskjöld M and Fadeel B: Raji revisited: Cytogenetics of
the original Burkitt's lymphoma cell line. Leukemia. 19:159–161.
2005.
|
|
10
|
Keklikoglou I, Koerner C, Schmidt C, Zhang
JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T,
Schneeweiss A, et al: MicroRNA-520/373 family functions as a tumor
suppressor in estrogen receptor negative breast cancer by targeting
NF-κB and TGF-β signaling pathways. Oncogene. 31:4150–4163. 2012.
View Article : Google Scholar
|
|
11
|
Brantley DM, Chen CL, Muraoka RS, Bushdid
PB, Bradberry JL, Kittrell F, Medina D, Matrisian LM, Kerr LD and
Yull FE: Nuclear factor-kappaB (NF-kappaB) regulates proliferation
and branching in mouse mammary epithelium. Mol Biol Cell.
12:1445–1455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oeckinghaus A and Ghosh S: The NF-kappaB
family of transcription factors and its regulation. Cold Spring
Harb Perspect Biol. 1:a0000342009. View Article : Google Scholar
|
|
13
|
Sun ZJ, Chen G, Hu X, Zhang W, Liu Y, Zhu
LX, Zhou Q and Zhao YF: Activation of PI3K/Akt/IKK-alpha/NF-kappaB
signaling pathway is required for the apoptosis-evasion in human
salivary adenoid cystic carcinoma: Its inhibition by quercetin.
Apoptosis. 15:850–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hutti JE, Pfefferle AD, Russell SC, Sircar
M, Perou CM and Baldwin AS: Oncogenic PI3K mutations lead to
NF-κB-dependent cytokine expression following growth factor
deprivation. Cancer Res. 72:3260–3269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang M and Kaufman RJ: The impact of the
endoplasmic reticulum protein-folding environment on cancer
development. Nat Rev Cancer. 14:581–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferreira AC, Robaina MC, Rezende LM,
Severino P and Klumb CE: Histone deacetylase inhibitor prevents
cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways
and leads to upregulation of miR-143, miR-145, and miR-101. Ann
Hematol. 93:983–993. 2014.PubMed/NCBI
|
|
17
|
Chiu CT, Chen JH, Chou FP and Lin HH:
Hibiscus sabdariffa leaf extract inhibits human prostate cancer
cell invasion via down-regulation of Akt/NF-κB/MMP-9 pathway.
Nutrients. 7:5065–5087. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bassères D and Baldwin A: NF-kappaB and
inhibitor of kappaB kinase pathways in oncogenic initiation and
progression. Oncogene. 25:6817–6830. 2006. View Article : Google Scholar
|
|
19
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dan HC, Cooper MJ, Cogswell PC, Duncan JA,
Ting JP and Baldwin AS: Akt-dependent regulation of NF-κB is
controlled by mTOR and Raptor in association with IKK. Genes Dev.
22:1490–1500. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu J, Tan Q, Deng B, Fang C, Qi D and Wang
R: The micro-RNA-520a-3p inhibits proliferation, apoptosis and
metastasis by targeting MAP3K2 in non-small cell lung cancer. Am J
Cancer Res. 5:802–811. 2015.
|
|
23
|
Mazan-Mamczarz K, Zhao XF, Dai B,
Steinhardt JJ, Peroutka RJ, Berk KL, Landon AL, Sadowska M, Zhang
Y, Lehrmann E, et al: Down-regulation of eIF4GII by miR-520c-3p
represses diffuse large B cell lymphoma development. PLoS Genet.
10:e10041052014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hosoi T, Hyoda K, Okuma Y, Nomura Y and
Ozawa K: Akt up- and down-regulation in response to endoplasmic
reticulum stress. Brain Res. 1152:27–31. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Verfaillie T, Garg AD and Agostinis P:
Targeting ER stress induced apoptosis and inflammation in cancer.
Cancer Lett. 332:249–264. 2013. View Article : Google Scholar
|
|
26
|
Clarke HJ, Chambers JE, Liniker E and
Marciniak SJ: Endoplasmic reticulum stress in malignancy. Cancer
Cell. 25:563–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Atkins C, Liu Q, Minthorn E, Zhang SY,
Figueroa DJ, Moss K, Stanley TB, Sanders B, Goetz A, Gaul N, et al:
Characterization of a novel PERK kinase inhibitor with antitumor
and antiangiogenic activity. Cancer Res. 73:1993–2002. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Binet F, Mawambo G, Sitaras N, Tetreault
N, Lapalme E, Favret S, Cerani A, Leboeuf D, Tremblay S, Rezende F,
et al: Neuronal ER stress impedes myeloid-cell-induced vascular
regeneration through IRE1α degradation of netrin-1. Cell Metab.
17:353–371. 2013. View Article : Google Scholar : PubMed/NCBI
|
